Cancer
Neoplasm of Uncertain Histogenesis
CI-CAN-00000034Explore in graph →
Non-malignant20,280 active trials259 approved drugs3,813 evidence items
Loading cancer entity…
Cancer
CI-CAN-00000034Explore in graph →
Clinical trials
91,351 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00516841 | A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer | terminated | Phase 2 | 16 | Facet BiotechINDUSTRY | 2 | Aug 23, 2012 | clinicaltrials |
| NCT00726869 | A Phase 1/2, Multi-center, Open-label, Dose-escalation Study of Elotuzumab(Humanized Anti-CS1 Monoclonal IgG1 Antibody) and Bortezomib in Subjects With Multiple Myeloma Following One to Three Prior Therapies. | terminated | Phase 1 | 28 | AbbottINDUSTRY | 1 | Aug 23, 2012 |
| clinicaltrials |
| NCT01359072 | Enhancing Coping Skills in Patients With Cancer | terminated | N/A | 1 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Aug 22, 2012 | clinicaltrials |
| NCT00093132 | Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy | terminated | Phase 1 / Phase 2 | 20 | AgennixINDUSTRY | 1 | Aug 17, 2012 | clinicaltrials |
| NCT00335959 | S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery | terminated | Phase 2 | 7 | SWOG Cancer Research NetworkNETWORK | 1 | Aug 17, 2012 | clinicaltrials |
| NCT00450970 | Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)(SPERA) | terminated | Phase 3 | 344 | AgennixINDUSTRY | 1 | Aug 17, 2012 | clinicaltrials |
| NCT00499681 | PhII Neo-Adjuvant Letrozole & Lapatinib in Pts w/HER2+ & Hormone Receptor+ Operable Breast CA SPORE | terminated | Phase 2 | 6 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Aug 10, 2012 | clinicaltrials |
| NCT00828620 | Positron Emission Tomography - Computed Tomography (PET-CT) Cetuximab Project | terminated | — | 21 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Aug 10, 2012 | clinicaltrials |
| NCT00611715 | Ph II Letrozole + OSI-774 (Tarceva) in Post-menopausal, w/ ER and/or PR-positive Met Breast Cancer. | terminated | Phase 2 | 48 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Aug 9, 2012 | clinicaltrials |
| NCT01597921 | A DB Randomized Study of R1 and R2 WaterJel / AloeVera Jell in Prevention of Radiation Dermatitis in Breast Cancer | terminated | — | 50 | Water-JelINDUSTRY | 1 | Aug 9, 2012 | clinicaltrials |
| NCT00388804 | External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer | terminated | Phase 3 | 39 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 8, 2012 | clinicaltrials |
| NCT01238653 | Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures | terminated | — | 8 | Pathfinder TherapeuticsINDUSTRY | 1 | Aug 8, 2012 | clinicaltrials |
| NCT00113321 | Low-Dose Decitabine in Myelodysplastic Syndrome Post Azacytidine Failure | terminated | Phase 2 | 16 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 7, 2012 | clinicaltrials |
| NCT00147238 | A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast | terminated | N/A | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 7, 2012 | clinicaltrials |
| NCT00409331 | Amifostine With IMRT for Submandibular and Sublingual Salivary Sparing During Head and Neck Cancer Treatment | terminated | Phase 2 | 3 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 7, 2012 | clinicaltrials |
| NCT00427583 | Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors | terminated | Phase 2 / Phase 3 | 11 | Novartis PharmaceuticalsINDUSTRY | 1 | Aug 7, 2012 | clinicaltrials |
| NCT00453193 | Alemtuzumab and Pentostatin In T-cell Neoplasms | terminated | Phase 2 | 26 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 7, 2012 | clinicaltrials |
| NCT00480987 | Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS) | terminated | Phase 1 / Phase 2 | 27 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 7, 2012 | clinicaltrials |
| NCT00509600 | Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia | terminated | Phase 2 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 7, 2012 | clinicaltrials |
| NCT00810576 | Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's Lymphoma | terminated | Phase 2 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 7, 2012 | clinicaltrials |
| NCT01222195 | Lenalidomide and Darbepoetin in Low-Intermediate Risk Myelodysplastic Syndrome (MDS) | terminated | Phase 2 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 7, 2012 | clinicaltrials |
| NCT01259284 | Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer | terminated | Phase 2 / Phase 3 | 2 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 7, 2012 | clinicaltrials |
| NCT00074763 | Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets | terminated | Phase 3 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 2, 2012 | clinicaltrials |
| NCT00085384 | PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer | terminated | Phase 1 / Phase 2 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 2, 2012 | clinicaltrials |
| NCT00443300 | Effectiveness of Protected Environment Rooms for AML and MDS | terminated | — | 3 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 2, 2012 | clinicaltrials |
| NCT00081887 | Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia | terminated | Phase 1 | 8 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00426829 | Proton Therapy and Bevacizumab for Primary Liver Tumors | terminated | Phase 1 | 3 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00499382 | Quantitation of Left Ventricular Ejection Fraction as Part of F-18 FDG Whole Body PET/CT Scans For Tumor Staging | terminated | — | 5 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00504985 | Fatigue in Emergency Center Patients | terminated | — | 14 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00513305 | Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia | terminated | Phase 3 | 67 | CephalonINDUSTRY | 2 | Aug 1, 2012 | clinicaltrials |
| NCT00632294 | Retrospective Study of the Biomechanical Properties of Large Allografts | terminated | — | 2 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00591539 | Carotid Artery Disease in Childhood Cancer Survivors | terminated | — | 3 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00901420 | Urodynamic Evaluation in Post-radiation Salvage Prostatectomy Patients | terminated | — | 2 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00062023 | Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer | terminated | Phase 2 | 12 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00514189 | Feasibility Study of Acute Myelogenous Leukemia mRNA Plus Lysate Loaded Dendritic Cell Vaccines | terminated | Phase 1 | 2 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00897806 | Identifying Genetic Markers That Predict Response to Paclitaxel in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer | terminated | — | 7 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT01103388 | Rituximab Maintenance After Autologous Transplantation | terminated | Phase 3 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00843050 | A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma | terminated | Phase 2 | 13 | Piramal Enterprises LimitedINDUSTRY | 2 | Jul 27, 2012 | clinicaltrials |
| NCT00899288 | Fingernails in Evaluating Bone Health in Postmenopausal Women With Breast Cancer Undergoing Hormone Therapy on Clinical Trial IBCSG-1-98 | terminated | Phase 3 | 60 | ETOP IBCSG Partners FoundationNETWORK | 0 | Jul 27, 2012 | clinicaltrials |
| NCT00127881 | Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome | terminated | Phase 3 | 76 | Emergent Product Development Seattle LLCINDUSTRY | 5 | Jul 26, 2012 | clinicaltrials |
| NCT01373463 | Cisplatin and Pemetrexed With Radiation Followed by Lobectomy(CisPemXetSrg) | terminated | Phase 1 | 48 | Medical University of South CarolinaOTHER | 1 | Jul 26, 2012 | clinicaltrials |
| NCT00003223 | SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth | terminated | Phase 2 | 5 | SWOG Cancer Research NetworkNETWORK | 1 | Jul 24, 2012 | clinicaltrials |
| NCT00006121 | Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy | terminated | Phase 2 | 18 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Jul 24, 2012 | clinicaltrials |
| NCT00074295 | S0310: Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Bronchoalveolar Lung Cancer | terminated | Phase 2 | 19 | SWOG Cancer Research NetworkNETWORK | 0 | Jul 24, 2012 | clinicaltrials |
| NCT00516542 | Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast Cancer | terminated | Phase 1 | 6 | OHSU Knight Cancer InstituteOTHER | 1 | Jul 24, 2012 | clinicaltrials |
| NCT01029509 | Study to Assess OPB-31121 in Advanced Leukemias or Myelodysplastic Syndromes | terminated | Phase 1 | 6 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 23, 2012 | clinicaltrials |
| NCT00488332 | An Exploratory Study on Optical Assessment of Oral Mucositis | terminated | — | 2 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 20, 2012 | clinicaltrials |
| NCT01645124 | Large-scale Trial Testing the Intensity of CYTOreductive Therapy in Polycythemia Vera (PV)(CYTO-PV) | terminated | Phase 3 | 365 | Consorzio Mario Negri SudOTHER | 1 | Jul 20, 2012 | clinicaltrials |
| NCT00010153 | ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer | terminated | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 19, 2012 | clinicaltrials |
| NCT00058266 | Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical Prostatectomy | terminated | Phase 2 | 36 | Northwestern UniversityOTHER | 1 | Jul 19, 2012 | clinicaltrials |
Data updated 24 days agoSource updated Aug 23, 2012source: clinicaltrials